Choosing the right device to regulate or jump-start the heart can be a challenge. Not only does a patient’s symptoms often dictate whether a pacemaker or defibrillator is a more appropriate treatment, but new advances in technology are making the choice between available devices more difficult.
Sorin Group's ELA Medical markets ISOLINE, a defibrillation lead designed with redundant insulation and abrasion resistant materials for longevity and safety.
March 10, 2008 – The Medical Imaging & Technology Alliance (MITA), a division of NEMA, today praised the 88 Members of ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
March 11, 2008 - St. Jude Medical Inc. received regulatory approval from the Ministry of Health, Labor and Welfare (MHLW ...
Nuance Communications Inc.'s on-demand offering for critical test result management (CTRM), Vocada Veriphy 2.0 is an end-to-end enterprise solution for communicating critical test results from hospital diagnostic departments to ordering clinicians.
March 10, 2008 - Royal Philips Electronics last week unveiled the HD7, the latest addition to its HD ultrasound family ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
March 10, 2008 - The FDA gave Siemens 510(k) market clearance of four new software applications used with the SOMATOM Definition aimed at simplifying the diagnosis of diseases of the heart, brain, lungs and extremity joints, as announced at ECR 2008, currently being held in Vienna.
NEC Display Solutions of America's MD205MG 5-megapixel flat-panel monitor is a grayscale display monitor that also forms the core of a new NEC medical bundled solution, said the company. The NEC MD205-DRV bundled solution reportedly includes two MD205MG displays and a high-performance video card for medical applications from Realvision.
March 7, 2008 – An individual’s physical health, psychological stress, social support and own sense of well-being, are all factors that can play a significant role in the likelihood of surviving an arrhythmic event, according to a study published in the March 2008 edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Siemens Healthcare now has available the DCA Vantage Analyzer, a point-of-care (POC) diabetes patient management ...
March 7, 2008 – KLAS recently named Toshiba’s Aquilion 64, Xario and Vantage 1.5T MR “Best in KLAS” in its Top 20 Year ...
GE's SnapShot Pulse offers improved dose reduction results for both diagnostic cardiac and neuro perfusion CT exams and ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 7, 2008 – CircuLite has advanced its Synergy Pocket Circulatory Assist Device clinical program into a 20-patient trial, after completion of a first-in-man pilot study of Synergy in four patients, as the company seeks CE Mark approval in the European Union for long-term implantation of Synergy in heart failure patients.
March 7, 2008 - Siemens Healthcare launched the DCA Vantage Analyzer, a point-of-care (POC) diabetes patient management ...
March 5, 2008 - The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Evaluation Agency ...
March 10, 2008
